Community-acquired infections and their association with myeloid malignancies

Cancer Epidemiology

Volumn 38, Issue 1, 2014, Pages 56-61

  Titmarsh, Glen J ^a   McMullin, Mary Frances ^b   McShane, Charlene M ^a   Clarke, Mike ^a   Engels, Eric A ^c   Anderson, Lesley A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Infection; Myeloid Malignancy; SEER Medicare

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BRONCHITIS; CANCER EPIDEMIOLOGY; CANCER RISK; CELLULITIS; CHRONIC MYELOID LEUKEMIA; COMMON COLD; COMMUNICABLE DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTITIS; DISEASE ASSOCIATION; FEMALE; GASTROENTERITIS; HERPES ZOSTER; HUMAN; INFLUENZA; LARYNGITIS; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; RISK ASSESSMENT; SINUSITIS; VERY ELDERLY;

INFECTION; MYELOID MALIGNANCY; SEER-MEDICARE;

AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MALE; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; SEER PROGRAM;

EID: 84894287660     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.10.009     Document Type: Article

References (35)

1. Seer.cancer.gov. SEER Cancer Statistics. seer.cancer.gov., 2013.
2. Wang L-L., Gao C., Chen B-A. Research progress on mechanism of MDS transformation into AML. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011, 19(February (1)):254-259.
3. Hoffbrand A.V., Moss P.A.H., Pettit J.E. Essential Haematology 2006, 378. Blackwell Publishing, Oxford. 5th ed.
4. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002, 100(October (7)):2292-2302.
5. Hjalgrim H., Engels Ea. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med 2008, 264(December (6)):537-548.
6. Kristinsson S.Y., Björkholm M., Hultcrantz M., Derolf Å.R., Landgren O., Goldin L.R. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol 2011, 29(July (21)):2897-2903.
7. Doody M.M., Linet M.S., Glass A.G., Friedman G.D., Pottern L.M., Boice J.D., et al. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control 1992, 3(September (5)):449-456.
8. Cooper G.S., Kamel F., Sandler D.P., Cooper S., Davey R., Bloomfield D. Risk of adult acute leukemia in relation to prior immune-related conditions. Cancer Epidemiol Biomarkers Prev 1996, 5:867-872.
9. Anderson L.A., Pfeiffer R.M., Landgren O., Gadalla S., Berndt S.I., Engels E.A. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 2009, 100(March (5)):822-828. Centre for Public Health, Queen's University Belfast, Northern Ireland, UK. l.anderson@qub.ac.uk.
10. Kristinsson S.Y., Landgren O., Samuelsson J., Bjorkholm M., Goldin L.R. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 2010, 95(July (7)):1216-1220. Department of Medicine, Division of Hematology, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden. sigurdur.kristinsson@karolinska.se.
11. Smeesters P.R., McMillan D.J., Sriprakash K.S. The streptococcal M protein: a highly versatile molecule. Trends Microbiol 2010, 18(June (6)):275-282.
12. Netea M.G., Kullberg B.J., Van der Meer J.W. Circulating cytokines as mediators of fever. Clin Infect Dis 2000, 31(October Suppl. (5)):S178-S184.
13. Van der Woude M.W., Bäumler A.J. Phase and antigenic variation in bacteria. Clin Microbiol Rev 2004, 17(July (3)):581-611. table of contents.
14. Timonen T.T. A hypothesis concerning deficiency of sunlight, cold temperature, and influenza epidemics associated with the onset of acute lymphoblastic leukemia in northern Finland. Ann Hematol 1999, 78(September (9)):408-414.
15. Rapp F., Cory J.M. Viral oncogenesis and the immune system. Cancer Detect Prev 1990, 14(January (4)):437-444.
16. Anderson L.A., Pfeiffer R., Warren J.L., Landgren O., Gadalla S., Berndt S.I., et al. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 2008, 17(11):3069-3075.
17. Engels Ea, Pfeiffer R.M., Ricker W., Wheeler W., Parsons R., Warren J.L. Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol 2011, 174(October (7)):860-870.
18. Ries Lag, et al. SEER Cancer Statistics Review. SEER Cancer Stat. Rev. 1975-2003 2006, Natl. Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2003/, based Novemb. 2005 SEER data submission, posted to SEER web site, 2006.
19. Fukuhara T., Kakinoki Y. Clinical features of a new category, myelodysplastic/myeloproliferative diseases, defined by WHO classification. Rinsho Byori 2006, 54(March (3)):243-249. Department of Medicine, Asahikawa City Hospital, Asahikawa 070-8610.
20. Zheng W., Linet M.S., Shu X.O., Pan R.P., Gao Y.T., Fraumeni J.F. Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China. Cancer Causes Control 1993, 4(July (4)):361-368.
21. Camous X., Pera A., Solana R., Larbi A. NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol 2012, (January):195956.
22. Gazit R., Weissman I.L., Rossi D.J. Hematopoietic stem cells and the aging hematopoietic system. Semin Hematol 2008, 45(October (4)):218-224.
23. Marley S.B., Gordon M.Y. Chronic myeloid leukaemia: stem cell derived but progenitor cell driven. ClinSci (Lond) 2005, 109(July (1)):13-25.
24. Scott J.D., Englund Ja, Myerson D., Geballe A.P. Influenza A pneumonia presenting as progressive focal infiltrates in a stem cell transplant recipient. J Clin Virol 2004, 31(October (2)):96-99.
25. Sakamoto S., Oiso N., Emoto M., Uchida S., Hirao A., Tatsumi Y., et al. Cellulitis with leukocytopenia as an initial sign of acute promyelocytic leukemia. Case Rep Dermatol 2012, 4(1):47-49.
26. Pomeroy C., Oken M.M., Rydell R.E., Filice G.A. Infection in the myelodysplastic syndromes. Am J Med 1991, 90(March (3)):338-344.
27. Chen C.-Y., Sheng W.-H., Cheng A., Chen Y.-C., Tsay W., Tang J.-L., et al. Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan. BMC Infect Dis 2011, 11(January (1)):250. BioMed Central Ltd.
28. Craig B.M., Rollison D.E., List A.F., Cogle C.R. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomarkers Prev 2012, 21(March (3)):474-481.
29. Jonte F., Fernández-Fuertes F., Cecchini C., Luño E., Ordóñez A., Fernández C., et al. Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia. Sangre (Barc) 1992, 37(October (5)):351-354.
30. Jonte F., Barez A., Soto I., Rayón C., Carrera D., Coma A., et al. Features of chronic myeloid leukemia at diagnosis, study of a series of 134 cases. Sangre (Barc) 1992, 37(October (5)):345-350.
31. Millett E.R.C., Quint J.K., Smeeth L., Daniel R.M., Thomas S.L. Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS ONE 2013, 8(January (9)):e75131.
32. Kroll M.E., Murphy F., Pirie K., Reeves G.K., Green J., Beral V. Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study. Br J Cancer 2012, 107(August (5)):879-887.
33. Strom S.S., Oum R., Elhor Gbito K.Y., Garcia-Manero G., Yamamura Y. De novo acute myeloid leukemia risk factors: a Texas case-control study. Cancer 2012, 118(September (18)):4589-4596.
34. Ma X., Park Y., Mayne S.T., Wang R., Sinha R., Hollenbeck A.R., et al. Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP cohort. Am J Epidemiol 2010, 171(February (3)):312-322.
35. Corman L.C. The relationship between nutrition, infection, and immunity. Med Clin North Am 1985, 69(May (3)):519-531.